Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Rank Gene Interaction Map Network Comparison Type Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 1375 to 1424 of 3228 in total
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent hydroxyacid oxidase 2 (ec 1.1.3.15) (haox2) ((s)-2-hydroxy-acid oxidase, peroxisomal) (long chain alpha-hydroxy acid oxidase) (long- chain l-2-hydroxy acid oxidase). [source:swissprot;acc:q9nyq3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2382\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4642.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4457.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04153\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent hydroxyacylglutathione hydrolase (ec 3.1.2.6) (glyoxalase ii) (glx ii). [source:swissprot;acc:q16775]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2398\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6970.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6707.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03918\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent hydroxyindole o-methyltransferase (ec 2.1.1.4) (hiomt) (acetylserotonin o-methyltransferase) (asmt). [source:swissprot;acc:p46597]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1919\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5783.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5444.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06233\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent hydroxymethylglutaryl-coa synthase, cytoplasmic (ec 2.3.3.10) (hmg-coa synthase) (3-hydroxy-3-methylglutaryl coenzyme a synthase). [source:swissprot;acc:q01581]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2303\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 7263.68\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6946.6\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.04565\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent hydroxymethylglutaryl-coa synthase, mitochondrial precursor (ec 2.3.3.10) (hmg-coa synthase) (3-hydroxy-3-methylglutaryl coenzyme a synthase). [source:swissprot;acc:p54868]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2301\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent hyporthetical protein mgc27169. [source:refseq;acc:nm\_176782]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2468\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 8004\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7765.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03074\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent hypoxanthine-guanine phosphoribosyltransferase (ec 2.4.2.8) (hgprt) (hgprtase). [source:swissprot;acc:p00492]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 420\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 11830.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 10235.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.15589\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent hypoxia-inducible factor-3 alpha isoform a; inhibitory pas domain protein. [source:refseq;acc:nm\_152794]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1007\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6249.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5707.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09485\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent i-kappa-b-interacting ras-like protein 2. [source:refseq;acc:nm\_017595]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1197\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6217.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5721.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0867\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent immature colon carcinoma transcript 1 (digestion substraction 1) (ds- 1). [source:swissprot;acc:q14197]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1045\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5862.09\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5364.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09279\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent immunoglobulin-binding protein 1 (cd79a-binding protein 1) (b cell signal transduction molecule alpha 4) (alpha 4 protein). [source:swissprot;acc:p78318]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1257\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5893.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5438.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0837\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent imp2 inner mitochondrial membrane protease-like; inner mitochondrial membrane peptidase 2 like. [source:refseq;acc:nm\_032549]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 357\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5950.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5061.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.17567\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent importin 4. [source:refseq;acc:nm\_024658]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1403\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6050.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5613.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07785\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent importin 7; ran-binding protein 7. [source:refseq;acc:nm\_006391]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1421\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6063.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5628.53\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.0773\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent importin 8; ran-binding protein 8. [source:refseq;acc:nm\_006390]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1422\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent importin 9. [source:refseq;acc:nm\_018085]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2860\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent importin alpha-1 subunit (karyopherin alpha-1 subunit) (srp1-beta) (rag cohort protein 2) (nucleoprotein interactor 1) (npi-1). [source:swissprot;acc:p52294]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1142\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6302.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5789.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0886\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent importin alpha-2 subunit (karyopherin alpha-2 subunit) (srp1-alpha) (rag cohort protein 1). [source:swissprot;acc:p52292]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2780\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent importin alpha-3 subunit (karyopherin alpha-3 subunit) (srp1-gamma). [source:swissprot;acc:o00505]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 801\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7169.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6456.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.1105\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent importin alpha-4 subunit (karyopherin alpha-4 subunit) (qip1 protein). [source:swissprot;acc:o00629]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 803\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7167.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6455.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11045\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent importin alpha-6 subunit (karyopherin alpha-5 subunit). [source:swissprot;acc:o15131]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1126\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6305.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5792.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08867\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent importin beta-1 subunit (karyopherin beta-1 subunit) (nuclear factor p97) (importin 90). [source:swissprot;acc:q14974]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 797\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7590.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6834.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11061\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent importin beta-2 subunit (karyopherin beta-2 subunit) (transportin) (m9 region interaction protein) (mip). [source:swissprot;acc:q92973]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2149\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6086.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5778.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0532\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent importin beta-3 subunit (karyopherin beta-3 subunit) (ran-binding protein 5). [source:swissprot;acc:o00410]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 904\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6785.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6167.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10031\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent importin-alpha re-exporter (chromosome segregation 1-like protein) (cellular apoptosis susceptibility protein). [source:swissprot;acc:p55060]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 701\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 8731.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7802.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11913\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent indolethylamine n-methyltransferase (ec 2.1.1.49) (aromatic alkylamine n-methyltransferase) (indolamine n-methyltransferase) (arylamine n- methyltransferase) (amine n-methyltransferase). [source:swissprot;acc:o95050]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1676\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6193.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5791.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0694\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent inflammation-related g protein-coupled receptor ex33. [source:refseq;acc:nm\_020370]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2714\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5583.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5603.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00351\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent inhibitor of growth family, member 1-like; inhibitor of growth 1-like. [source:refseq;acc:nm\_001564]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2739\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4890.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4877.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00264\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent inhibitor of growth family, member 1; inhibitor of growth 1. [source:refseq;acc:nm\_005537]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2736\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4902.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4887.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00296\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent inorganic pyrophosphatase (ec 3.6.1.1) (pyrophosphate phospho- hydrolase) (ppase). [source:swissprot;acc:q15181]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1901\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5530.11\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5204.25\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.06261\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent inorganic pyrophosphatase 2 isoform 1. [source:refseq;acc:nm\_176869]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1902\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent inosine-5'-monophosphate dehydrogenase 1 (ec 1.1.1.205) (imp dehydrogenase 1) (impdh-i) (impd 1). [source:swissprot;acc:p20839]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2245\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6049.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5776.96\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.0472\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent inosine-5'-monophosphate dehydrogenase 2 (ec 1.1.1.205) (imp dehydrogenase 2) (impdh-ii) (impd 2). [source:swissprot;acc:p12268]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2243\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent inositol polyphosphate 5-phosphatase ocrl-1 (ec 3.1.3.36) (lowe's oculocerebrorenal syndrome protein). [source:swissprot;acc:q01968]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1981\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5800.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5475.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.05939\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent inositol polyphosphate multikinase. [source:refseq;acc:nm\_152230]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1542\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5865.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5466\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07306\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent inositol polyphosphate-4-phosphatase, type 1 isoform b; inositol polyphosphate-4-phosphatase, type i, 107kd; 4-phosphatase i; inositol polyphosphate-4-phosphatase i. [source:refseq;acc:nm\_001566]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 559\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 7007.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6167.93\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.13615\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent inositol polyphosphate-4-phosphatase, type ii, 105kd; inositol polyphosphate 4-phosphatase ii; 4-phosphatase ii. [source:refseq;acc:nm\_003866]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 557\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent inositol polyphosphate-5-phosphatase; phosphatidylinositol polyphosphate 5-phosphatase type iv; phosphatidylinositol (4,5) bisphosphate 5-phosphatase. [source:refseq;acc:nm\_019892]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2912\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent inositol-1(or 4)-monophosphatase (ec 3.1.3.25) (impase) (imp) (inositol monophosphatase) (lithium-sensitive myo-inositol monophosphatase a1). [source:swissprot;acc:p29218]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1717\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6484.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6069.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06842\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent inositol-1(or 4)-monophosphatase 2 (ec 3.1.3.25) (impase 2) (imp 2) (inositol monophosphatase 2) (myo-inositol monophosphatase a2). [source:swissprot;acc:o14732]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1716\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6485.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6070.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06844\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent insulin gene enhancer protein isl-1 (islet-1). [source:swissprot;acc:p20663]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2626\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7534.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7424.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01479\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent insulin gene enhancer protein isl-2 (islet-2). [source:swissprot;acc:q96a47]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2638\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7525.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7433.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0123\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent integral membrane protein 2a (e25 protein). [source:swissprot;acc:o43736]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 986\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6976.1\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6362.64\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.09642\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent integral membrane protein 2b (transmembrane protein bri) [contains: abri/adan amyloid peptide]. [source:swissprot;acc:q9y287]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 984\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent integral membrane protein 2c (transmembrane protein bri3) (npd018). [source:swissprot;acc:q9nqx7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 985\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent integral membrane protein cii-3b. [source:sptrembl;acc:o75609]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2511\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6415.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6256.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02535\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent integrin alpha-3 precursor (galactoprotein b3) (gapb3) (vla-3 alpha chain) (cd49c). [source:swissprot;acc:p26006]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 3224\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent integrin alpha-6 precursor (vla-6) (cd49f). [source:swissprot;acc:p23229]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 3158\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent integrin alpha-7 precursor. [source:swissprot;acc:q13683]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2978\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent integrin beta-1 precursor (fibronectin receptor beta subunit) (cd29 antigen) (integrin vla-4 beta subunit). [source:swissprot;acc:p05556]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2905\vspace{3pt}}&&&\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/